Modifying responses to antipsychotic drugs
Nature Neuroscience
August 6, 2012
Chronic treatment with antipsychotic drugs induces modifications to histones, the proteins around which DNA wraps, which may hinder the responses to these drugs. These findings from this mouse study, reported online this week in Nature Neuroscience, suggest that inhibiting the modification of histones may improve their efficacy.
Javier Gonzalez-Maeso and colleagues report that mice treated chronically with antipsychotic drugs have modifications to histones that reduced the expression of glutamate receptors in the frontal cortex of mice. This reduction in glutamate receptors was also associated with increased schizophrenia-like behaviors in the mice. Treating the mice with a drug that prevented these histone modifications reversed this effect.
Previous clinical studies have found that combining antipsychotic drugs with valproate, a drug that is known to prevent the histone modifications studied here, can increase the therapeutic benefits of antipsychotic drugs. This study suggests a mechanism by which valproate (and other drugs that target histone modifications) could increase the therapeutic benefit of antipsychotic treatment.
doi: 10.1038/nn.3181
Research highlights
-
May 12
Geoscience: Monitoring earthquakes at the speed of lightNature
-
May 4
Microbiology: Bacteriophage therapy helps treat multi-drug resistant infection in an immunocompromised patientNature Communications
-
Apr 27
Planetary science: Building blocks of DNA detected in meteoritesNature Communications
-
Apr 8
Health: Psilocybin use associated with lower risk of opioid addictionScientific Reports
-
Apr 5
Energy: Winterizing the Texan energy infrastructure pays off in the long termNature Energy
-
Mar 17
Neuroscience: Sample size matters in studies linking brain scans to behaviourNature
